Analytical Solutions for Monitoring Psychedelics

Time: 12:05 pm
day: Day One Track A AM

Details:

  • GMP analytical certification services for testing controlled substances including narcotics and psychedelics.
  • Characterization of innovative neuropsychiatric therapeutics including Psilocybin (depression), MDMA (post-traumatic stress disorder), Ibogaine (addiction) and LSD tartrate (anxiety disorder) along with DMT, 5-MeO-DMT, Ketamine, THC and many other psychedelic medicines.
  • Our work focuses on developing analytical tools to evaluate potential therapeutic psychedelic treatments and their derivatives.

Speakers: